603590.SS
Price:
$43.19
Market Cap:
$6.78B
Beijing Konruns Pharmaceutical Co.,Ltd. engages in the research, production, and sale of various drugs in China. The company offers Su Ling product in the hemagglutinin preparation market used to reduce bleeding during surgery and control postoperative surgery. It also engages in the development of drug candidates, including CX1026, CX1003, and KC1036. The company was founded in 2003 and is headquartered in Beijing, China.
Industry
Biotechnology
IPO Date
2018-09-03
Stock Exchange
SHH
Ticker
603590.SS
According to Beijing Konruns Pharmaceutical Co.,Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is 119.97. This represents a change of 413.49% compared to the average of 23.36 of the last 4 quarters.
The mean historical PE Ratio of Beijing Konruns Pharmaceutical Co.,Ltd. over the last ten years is 32.10. The current 119.97 PE Ratio has changed 37.27% with respect to the historical average. Over the past ten years (40 quarters), 603590.SS's PE Ratio was at its highest in in the December 2023 quarter at 824.65. The PE Ratio was at its lowest in in the December 2022 quarter at -447.61.
Average
32.10
Median
27.09
Minimum
8.78
Maximum
87.11
Discovering the peaks and valleys of Beijing Konruns Pharmaceutical Co.,Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 119.61%
Maximum Annual PE Ratio = 87.11
Minimum Annual Increase = -59.90%
Minimum Annual PE Ratio = 8.78
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | 87.11 | 119.61% |
| 2023 | 39.67 | 3.15% |
| 2022 | 38.46 | 11.26% |
| 2021 | 34.56 | 7.11% |
| 2020 | 32.27 | 53.68% |
| 2019 | 21.00 | 33.30% |
| 2018 | 15.75 | 79.32% |
| 2017 | 8.78 | -59.90% |
| 2016 | 21.91 | 1.88% |
| 2015 | 21.50 | -9.82% |
The current PE Ratio of Beijing Konruns Pharmaceutical Co.,Ltd. (603590.SS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
55.08
5-year avg
46.41
10-year avg
32.10
Beijing Konruns Pharmaceutical Co.,Ltd.’s PE Ratio is greater than Kexing Biopharm Co., Ltd. (51.69), greater than Wuhan Keqian Biology Co.,Ltd (15.79), greater than Hunan Jiudian Pharmaceutical Co., Ltd. (17.14), greater than Zhejiang Ausun Pharmaceutical Co., Ltd. (43.42), greater than Hangzhou Biotest Biotech Co.,Ltd. (38.02), greater than Anhui Huaheng Biotechnology Co., Ltd. (45.93), greater than Xiangxue Pharmaceutical Co.,Ltd. (-6.12), greater than Guilin Sanjin Pharmaceutical Co., Ltd. (16.95), greater than Guizhou Xinbang Pharmaceutical Co., Ltd. (95.66), less than Chengdu Olymvax Biopharmaceuticals Inc. (176.15),
| Company | PE Ratio | Market cap |
|---|---|---|
| 51.69 | $6.49B | |
| 15.79 | $7.29B | |
| 17.14 | $8.05B | |
| 43.42 | $8.05B | |
| 38.02 | $5.71B | |
| 45.93 | $8.62B | |
| -6.12 | $6.14B | |
| 16.95 | $8.76B | |
| 95.66 | $7.56B | |
| 176.15 | $11.33B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Beijing Konruns Pharmaceutical Co.,Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Beijing Konruns Pharmaceutical Co.,Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Beijing Konruns Pharmaceutical Co.,Ltd.'s PE Ratio?
How is the PE Ratio calculated for Beijing Konruns Pharmaceutical Co.,Ltd. (603590.SS)?
What is the highest PE Ratio for Beijing Konruns Pharmaceutical Co.,Ltd. (603590.SS)?
What is the 3-year average PE Ratio for Beijing Konruns Pharmaceutical Co.,Ltd. (603590.SS)?
What is the 5-year average PE Ratio for Beijing Konruns Pharmaceutical Co.,Ltd. (603590.SS)?
How does the current PE Ratio for Beijing Konruns Pharmaceutical Co.,Ltd. (603590.SS) compare to its historical average?